169 related articles for article (PubMed ID: 11023533)
1. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging.
Kelavkar UP; Cohen C; Kamitani H; Eling TE; Badr KF
Carcinogenesis; 2000 Oct; 21(10):1777-87. PubMed ID: 11023533
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB
Neoplasia; 2004; 6(6):821-30. PubMed ID: 15720809
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
6. 15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells.
Kelavkar UP; Cohen C
Neoplasia; 2004; 6(1):41-52. PubMed ID: 15068670
[TBL] [Abstract][Full Text] [Related]
7. 15-lipoxygenase-1 overexpression in prostate adenocarcinoma.
Kelavkar U; Cohen C; Eling T; Badr K
Adv Exp Med Biol; 2002; 507():133-45. PubMed ID: 12664577
[No Abstract] [Full Text] [Related]
8. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma.
Gupta S; Srivastava M; Ahmad N; Sakamoto K; Bostwick DG; Mukhtar H
Cancer; 2001 Feb; 91(4):737-43. PubMed ID: 11241241
[TBL] [Abstract][Full Text] [Related]
9. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR
Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855
[TBL] [Abstract][Full Text] [Related]
10. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
11. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
13. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
[TBL] [Abstract][Full Text] [Related]
14. Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation.
Iemelynova AA; Grygorenko VM; Cheremuha SV; Romanenko AM
Exp Oncol; 2009 Dec; 31(4):246-9. PubMed ID: 20010526
[TBL] [Abstract][Full Text] [Related]
15. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
Kelavkar UP; Parwani AV; Shappell SB; Martin WD
Neoplasia; 2006 Jun; 8(6):510-22. PubMed ID: 16820097
[TBL] [Abstract][Full Text] [Related]
16. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features.
Machtens S; Serth J; Bokemeyer C; Bathke W; Minssen A; Kollmannsberger C; Hartmann J; Knüchel R; Kondo M; Jonas U; Kuczyk M
Int J Cancer; 2001 Sep; 95(5):337-42. PubMed ID: 11494236
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 15-lipoxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells.
Jayawickreme SP; Gray T; Nettesheim P; Eling T
Am J Physiol; 1999 Apr; 276(4):L596-603. PubMed ID: 10198357
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
19. Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients.
Song SY; Kim SR; Ahn G; Choi HY
Prostate Cancer Prostatic Dis; 2003; 6(2):143-7. PubMed ID: 12806373
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma.
Kallakury BV; Figge J; Ross JS; Fisher HA; Figge HL; Jennings TA
Hum Pathol; 1994 Jan; 25(1):92-7. PubMed ID: 7508886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
